Reversibility of MAO inhibition.
D000328:Adult; D005260:Female; D006801:Humans; D008995:Monoamine Oxidase / Q000378:metabolism*; D008996:Monoamine Oxidase Inhibitors / Q000009:adverse effects / Q000494:pharmacology*; D010624:Phenelzine / Q000009:adverse effects / Q000494:pharmacology; D013375:Substance Withdrawal Syndrome / Q000378:metabolism; D014191:Tranylcypromine / Q000009:adverse effects / Q000494:pharmacology
D008996:Monoamine Oxidase Inhibitors; D014191:Tranylcypromine; D008995:Monoamine Oxidase; D010624:Phenelzine